Abstract
The application of metabolomic associated to CKD is particularly attractive, for these molecules are associated not only to the reduction of renal excretion and identification of new biomarkers, but with the microbiote and metabolic alterations that constantly occur in the animal organism. With the possibility of identifying these new metabolytes, mechanisms correlated with the physiopath…